US Stocks
/
Neurogene Inc. Share Price
Neurogene Inc. Share Price

Neurogene Inc. Share Price

NASDAQ: NGNE | Small Cap
$26.44
+$0.56 (2.16%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neurogene Inc. Stock Performance

Open
$26.50
Prev. Close
$25.88
Circuit Range
N/A
Day Range
$26.25 - $27.59
Year Range
$16.00 - $43.39
Volume
8,951
Average Traded
$26.67

Neurogene Inc. Share Price Today

As of 9 October 2026, Neurogene Inc.'s share price is $26.44. The stock opened at $26.50, compared to its previous close of $25.88. During today's trading session, Neurogene Inc.'s share price traded between $26.25 and $27.59, with an average price of $26.92. Over the past 52 weeks, the stock has recorded a high of $43.39 and a low of $16.00. In terms of performance, Neurogene Inc.'s share price has risen by 1.38% over the last six months and is down 22.81% on a year-on-year basis.

Neurogene Inc. Share Price Chart

$26.25$27.59
L
Show Current Price
H

Neurogene Inc. Stock Fundamentals & Key Indicators

Market Cap
$563.87M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.55
Revenue (TTM)
$0.00
Return On Equity (TTM)
-51.17%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-64.63%

Neurogene Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$20.95-$24.74-$30.93-$34.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-18.09%-25.02%-11.51%

Neurogene Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.93$0.00
Net Profit-$36.32-$75.14-$90.35
Net Profit MarginN/A-8079.57%N/A
Income ChangeN/A-106.88%-20.24%

About Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Neurogene Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$27.27
$26.52
-4.88%
Sep 2026
$36.01
$27.88
-25.96%
Aug 2026
$33.60
$37.66
+14.84%
Jul 2026
$32.46
$32.79
+4.68%
Jun 2026
$28.57
$31.32
+11.10%
May 2026
$24.88
$28.20
+8.11%
Apr 2026
$21.28
$26.08
+28.98%
Mar 2026
$23.02
$20.22
-13.88%
Feb 2026
$18.11
$23.48
+33.48%
Jan 2026
$20.42
$17.59
-15.29%
Dec 2025
$20.13
$20.77
-1.68%
Nov 2025
$30.52
$21.12
-38.34%

NGNE Share Price FAQs

What is Neurogene Inc. share price today?

chevron-up
Neurogene Inc. share price today is $26.44 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Neurogene Inc. stock?

chevron-up
The 52 week high of Neurogene Inc. stock is $43.39, while the 52 week low is $16.00 as of 9 Oct '26.

What is NGNE's market capitalisation today?

chevron-up
NGNE market capitalisation is $563.87M as of October 9, 2026, at 4:48 pm IST.

What is NGNE's net income for the last quarter?

chevron-up
NGNE's net income for the last quarter is -34.49B USD.

What is the 5 year returns of NGNE?

chevron-up
The 5 year returns of NGNE is -81.96% as on 9 Oct '26.

What is the high & low stock price of NGNE today?

chevron-up
NGNE stock price hit a high of $27.59 and low of $26.25 as of 9 Oct '26.

Can I buy NGNE shares in India?

chevron-up
Yes. You can buy NGNE in India by opening an international trading account.